| Electromanipulation of cells U Zimmermann, GA Neil CRC press, 1996 | 375 | 1996 |
| Antineutrophil cytoplasmic antibody in inflammatory bowel and hepatobiliary diseases: high prevalence in ulcerative colitis, primary sclerosing cholangitis, and autoimmune … S Hardarson, DR Labrecqu, FA Mitros, GA Neil, JA Goeken American journal of clinical pathology 99 (3), 277-281, 1993 | 141 | 1993 |
| Randomized comparison of differing periods of twice‐a‐day triple therapy for the eradication of Helicobacter pylori L Laine, R Estrada, M Trujillo, K Fukanaga, G Neil Alimentary pharmacology & therapeutics 10 (6), 1029-1033, 1996 | 119 | 1996 |
| The effect of high intensity electric field pulses on eukaryotic cell membranes: fundamentals and applications U Zimmermann, GA Neil Electromanipulation of cells 1, 106, 1996 | 110 | 1996 |
| [14] Electrofusion GA Neil, U Zimmermann Methods in enzymology 220, 174-196, 1993 | 92 | 1993 |
| Twice-daily, 10-day triple therapy with omeprazole, amoxicillin, and clarithromycin forHelicobacter pylorieradication in duodenal ulcer disease: results of three multicenter … L Laine, L Suchower, J Frantz, A Connors, G Neil Official journal of the American College of Gastroenterology| ACG 93 (11 …, 1998 | 86 | 1998 |
| Drainage of the gallbladder in patients with acute acalculous cholecystitis by transpapillary endoscopic cholecystotomy FC Johlin Jr, GA Neil Gastrointestinal endoscopy 39 (5), 645-651, 1993 | 70 | 1993 |
| Monoclonal antibody analysis of a unique macrophage procoagulant activity induced by murine hepatitis virus strain 3 infection LS Fung, G Neil, J Leibowitz, EH Cole, S Chung, A Crow, GA Levy Journal of Biological Chemistry 266 (3), 1789-1795, 1991 | 66 | 1991 |
| Limited Efficacy of Omeprazole--based Dual and Triple Therapy for Helicobacter pylori: A Randomized Trial Employing" Optimal" Dosing. L Laine, C Stein, G Neil American Journal of Gastroenterology (Springer Nature) 90 (9), 1995 | 51 | 1995 |
| Nerve growth factor synthesis by intestinal epithelial cells GW Varilek, GA Neil, WP Bishop, J Lin, NJ Pantazis American Journal of Physiology-Gastrointestinal and Liver Physiology 269 (3 …, 1995 | 48 | 1995 |
| Caco-2 cells express type I interleukin-1 receptors: ligand binding enhances proliferation GW Varilek, GA Neil, WP Bishop American Journal of Physiology-Gastrointestinal and Liver Physiology 267 (6 …, 1994 | 41 | 1994 |
| Endoscopic biopsy requirements for post-treatment diagnosis of Helicobacter pylori L Laine, J Sugg, L Suchower, G Neil Gastrointestinal endoscopy 51 (6), 664-669, 2000 | 38 | 2000 |
| Macrophages synthesize factor X and secrete factor X/Xa-containing prothrombinase activity into the surrounding medium G Pejler, C Lunderius, B Tomasini-Johansson Thrombosis and haemostasis 84 (09), 429-435, 2000 | 38 | 2000 |
| Low rate of emergence of clarithromycin‐resistant Helicobacter pylori with amoxycillin co‐therapy L Laine, L Suchower, J Frantz, A Connors, G Neil Alimentary pharmacology & therapeutics 12 (9), 887-892, 1998 | 38 | 1998 |
| Correcting β-thalassemia by combined therapies that restrict iron and modulate erythropoietin activity C Casu, M Pettinato, A Liu, M Aghajan, V Lo Presti, MR Lidonnici, ... Blood, The Journal of the American Society of Hematology 136 (17), 1968-1979, 2020 | 37 | 2020 |
| Efficient generation of stable antibody forming hybridoma cells by electrofusion JJ Schmitt, U Zimmermann, GA Neil Hybridoma 8 (1), 107-115, 1989 | 35 | 1989 |
| Levels of the TNF-related cytokine LIGHT increase in hospitalized COVID-19 patients with cytokine release syndrome and ARDS DS Perlin, I Zafir-Lavie, L Roadcap, S Raines, CF Ware, GA Neil MSphere 5 (4), 10.1128/msphere. 00699-20, 2020 | 33 | 2020 |
| Time of Helicobacter pylori Eradication Assessment Following Treatment GA Neil, LJ Suchower, PD Ronca, ML Skoglund Helicobacter 2 (1), 13-20, 1997 | 33 | 1997 |
| Realigning the LIGHT signaling network to control dysregulated inflammation CF Ware, M Croft, GA Neil Journal of Experimental Medicine 219 (7), e20220236, 2022 | 32 | 2022 |
| Successful intracranial delivery of trastuzumab by gene-therapy for treatment of HER2-positive breast cancer brain metastases I Zafir-Lavie, S Sherbo, H Goltsman, F Badinter, E Yeini, P Ofek, R Miari, ... Journal of Controlled Release 291, 80-89, 2018 | 32 | 2018 |
Shany BlumPG Medical Systems在 pgmeds.com 的电子邮件经过验证
